Apr 17, 2009 by Brian Orelli, PhDCost-Cutting? Check. Increased Sales? Hmm …Amylin has half the equation. Now it needs the other half.
Apr 17, 2009 by Brian Orelli, PhDWhen Revenue Trumps EarningsBiogen grows earnings, but what does that say about the future.
Apr 16, 2009 by Brian Orelli, PhDIcahn: Ludicrous and ArrogantFun to read, but does he have the best intentions for long-term shareholders?
Apr 16, 2009 by Brian Orelli, PhD2 Virus Killers Are Better Than 1Glaxo brings Pfizer under its HIV wing.
Apr 15, 2009 by Brian Orelli, PhDNo Bumper Crop, but Bans Aplenty for MonsantoGermany's move won't be a major hit to sales, but it's the thought that counts.
Apr 15, 2009 by Brian Orelli, PhDJohnson & Johnson Still Withstands RecessionHooray for health care; it didn't fall as much as everything else.
Apr 14, 2009 by Brian Orelli, PhDSell Dendreon! No, Buy Dendreon!After such a huge one-day run-up, what should investors do?
Apr 13, 2009 by Brian Orelli, PhDWill These Drugs Get Past the FDA?Hopefully April doesn't bring showers of tears to these drugmakers.
Apr 13, 2009 by Brian Orelli, PhDPrescriptions for AcquisitionsExpress Scripts joins the health-care M&A parade.
Apr 9, 2009 by Brian Orelli, PhDThe Side Effects of CompetitionIt's often the competitors that determine how bad the side effects can be.
Apr 9, 2009 by Brian Orelli, PhDCash: The Cure for Smaller DrugmakersWhat's good for the heart is good for the pocketbook.
Apr 8, 2009 by Brian Orelli, PhDI'm Rich! I'm Ruined! Overreaction Equals OpportunityKnowing your company lets you judge when the market has overreacted.
Apr 7, 2009 by Brian Orelli, PhDBristol-Myers Squibb: On the Patent Cliff's EdgeThe fall is still going to hurt.
Apr 7, 2009 by Brian Orelli, PhDPfizer's Mind MeldIs it just rearranging the deck chairs on a sinking ship?
Apr 6, 2009 by Brian Orelli, PhDFDA to Search Engines: You Lose!FDA cracks down on pharma ads, but search engines are the real losers.
Apr 4, 2009 by Brian Orelli, PhDThe Wrong Way to Invest in the Right StocksExchange-traded funds don't work for this industry.
Apr 3, 2009 by Brian Orelli, PhDToning Down a TreatmentElan and Wyeth drop the highest dose of their Alzheimer's drug.
Apr 3, 2009 by Brian Orelli, PhDPfizer + Sutent = One Exciting Roller CoasterThis time on the down slope, unfortunately.
